[REMARKS ON SUFFICIENT LABELING OF DRUGS].
D003875:Drug Eruptions; D004342:Drug Hypersensitivity; D004345:Drug Industry; D004485:Eczema; D007878:Legislation as Topic; D009450:Neurodermatitis; D010489:Periarthritis; D011693:Purpura; D013557:Switzerland; D014116:Toxicology
DERMATITIS MEDICAMENTOSA; DRUG HYPERSENSITIVITY; DRUG INDUSTRY; ECZEMA; LEGISLATION; NEURODERMATITIS; PERIARTHRITIS; PURPURA; SWITZERLAND; TOXICOLOGIC REPORT
BEMERKUNGEN ZUR VOLLDEKLARATION DER HEILMITTEL.